A detailed history of Pro Share Advisors LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 41,096 shares of PGEN stock, worth $58,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,096
Previous 38,269 7.39%
Holding current value
$58,356
Previous $51,000 15.69%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$1.21 - $1.75 $3,420 - $4,947
2,827 Added 7.39%
41,096 $59,000
Q4 2023

Feb 14, 2024

BUY
$0.89 - $1.41 $3,572 - $5,659
4,014 Added 11.72%
38,269 $51,000
Q3 2023

Nov 13, 2023

BUY
$1.08 - $1.85 $163 - $279
151 Added 0.44%
34,255 $48,000
Q2 2023

Aug 10, 2023

BUY
$0.96 - $1.4 $2,250 - $3,281
2,344 Added 7.38%
34,104 $39,000
Q1 2023

May 11, 2023

BUY
$0.88 - $2.19 $1,370 - $3,409
1,557 Added 5.16%
31,760 $33,000
Q4 2022

Feb 02, 2023

BUY
$1.27 - $2.26 $1,988 - $3,539
1,566 Added 5.47%
30,203 $45,000
Q3 2022

Nov 04, 2022

BUY
$1.41 - $2.79 $1,584 - $3,135
1,124 Added 4.09%
28,637 $61,000
Q2 2022

Aug 01, 2022

SELL
$1.15 - $2.53 $13,413 - $29,509
-11,664 Reduced 29.77%
27,513 $37,000
Q1 2022

May 10, 2022

SELL
$1.91 - $3.98 $20,291 - $42,283
-10,624 Reduced 21.33%
39,177 $83,000
Q4 2021

Feb 08, 2022

SELL
$3.53 - $5.5 $22,934 - $35,733
-6,497 Reduced 11.54%
49,801 $185,000
Q3 2021

Nov 12, 2021

SELL
$4.99 - $6.55 $26,836 - $35,225
-5,378 Reduced 8.72%
56,298 $281,000
Q2 2021

Aug 13, 2021

BUY
$6.24 - $8.22 $93,537 - $123,217
14,990 Added 32.11%
61,676 $402,000
Q1 2021

May 14, 2021

BUY
$6.74 - $10.95 $22,868 - $37,153
3,393 Added 7.84%
46,686 $322,000
Q4 2020

Feb 09, 2021

BUY
$3.75 - $10.56 $27,776 - $78,217
7,407 Added 20.64%
43,293 $442,000
Q3 2020

Nov 13, 2020

SELL
$3.5 - $6.2 $1,729 - $3,062
-494 Reduced 1.36%
35,886 $126,000
Q2 2020

Aug 03, 2020

BUY
$2.16 - $5.46 $20,999 - $53,082
9,722 Added 36.47%
36,380 $182,000
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $38,920 - $191,671
26,658 New
26,658 $91,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $296M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.